Macquarie Home | Course Handbook | Library | Campus Map | Macquarie Contacts
Home page

Macquarie University ResearchOnline

Home
Add
-List Of Titles -Effect of olmesartan on oxidative stress in hemodialysis patients

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.14/70039

OpenURL Link
43 Visitors 48 Hits 2 Downloads
Title
Effect of olmesartan on oxidative stress in hemodialysis patients
Related
Hypertension research, Vol. 30, Issue 5, p.395-402
DOI
10.1291/hypres.30.395
Publisher
Japanese Society of Hypertension
Date
2007
FoR/RFCD Code(s)
030501 Free Radical Chemistry  060101 Analytical Biochemistry
Author/Creator
Kadowaki, Daisuke
Author/Creator
Anraku, Makoto
Author/Creator
Tasaki, Yuka
Author/Creator
Kitamura, Kenichiro
Author/Creator
Wakamatsu, Shiho
Author/Creator
Tomita, Kimio
Author/Creator
Gebicki, Janusz M
Author/Creator
Maruyama, Toru
Author/Creator
Otagiri, Masaki
Description
The effect of olmesartan, an inverse angiotensin II type 1 receptor blocker (ARB), on oxidative stress in hemodialysis (HD) patients is not fully understood, and has not been widely investigated in vitro or in vivo. We determined the amount of oxidized albumin and albumin hydroperoxides formed during incubation in the absence and presence of olmesartan by high-performance liquid chromatography (HPLC) and by a ferrous oxidation xylenol assay in an in vitro study. Six hypertensive HD patients were treated with 40 mg of olmesartan once daily, and blood pressure monitoring (BPM) was performed after 0, 4, and 8 weeks of treatment. The ratio of oxidized to unoxidized albumin was also determined. The oxidized albumin ratios and levels of albumin hydroperoxides were significantly decreased in a concentration-dependent manner in the presence of olmesartan, compared with the absence of olmesartan (p<0.05) in in vitro studies. In HD patients, olmesartan also significantly reduced systolic and diastolic blood pressure after 4 weeks, with a further significant decrease after 8 weeks. The ratio of oxidized to unoxidized albumin was markedly decreased after 4 weeks and these lower levels were maintained at 8 weeks. Olmesartan effectively lowered the extent of oxidation of albumin in both in vitro and in vivo studies, and this effect might confer benefits beyond a reduction in blood pressure.
Description
8 page(s)
Subject Keyword
030501 Free Radical Chemistry
Subject Keyword
060101 Analytical Biochemistry
Subject Keyword
olmesartan
Subject Keyword
blood pressure
Subject Keyword
oxidative stress
Subject Keyword
hemodialysis
Subject Keyword
albumin
Resource Type
journal article
Organisation
Macquarie University. Dept. of Biological Sciences

Identifier
http://hdl.handle.net/1959.14/70039
Identifier
ISSN:1348-4214
Identifier
mq-rm-2007002994
Language
eng
Reviewed
Reviewed
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Hypertension research"
 
OR
  • Show All  
  • Show My Selections 
Advanced Search

Search

albumin

Browse

  • By Title 
  • By Author/Creator 
  • By Department/Centre 
  • By Subject Keyword 
  • By Journal/Conference 
  • By FoR/RFCD codes 
  • By Resource Type 
  • By Date 

Highlights

  • Most Accessed Objects 
  • Recent Additions 
  • Pending Publications 
  • Author Profiles 

Resources

  • About ResearchOnline 
  • FAQ 
  • Open Access 
  • Open Access-FAQs 
  • Copyright 
  • Contribute 
  • Help 
  • Contact
  • Terms and Conditions 
Valid XHTML 1.0 Strict Powered by VITAL

Copyright Macquarie University | Privacy Statement | Accessibility Information

ABN 90 952 801 237 | CRICOS Provider No 00002J

Library Staff Sign In